Using specialist screening practitioners (SSPs) to increase uptake of bowel scope (flexible sigmoidoscopy) screening: results of a feasibility single-stage phase II randomised trial.
Adult
Colorectal Neoplasms
/ diagnosis
Early Detection of Cancer
/ methods
Feasibility Studies
Female
Humans
Male
Mass Screening
/ methods
Patient Acceptance of Health Care
Patient Navigation
/ economics
Patient Satisfaction
/ statistics & numerical data
Reminder Systems
Sigmoidoscopy
/ statistics & numerical data
bowel scope
colorectal cancer
feasibility
patient navigation
screening
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
15 02 2019
15 02 2019
Historique:
entrez:
18
2
2019
pubmed:
18
2
2019
medline:
4
3
2020
Statut:
epublish
Résumé
To determine the feasibility of specialist screening practitioners (SSPs) offering patient navigation (PN) to facilitate uptake of bowel scope screening (BSS) among patients who do not confirm or attend their appointment. A single-stage phase II trial. South Tyneside District Hospital, Tyne and Wear, England, UK. Individuals invited for BSS at South Tyneside District Hospital during the 6-month recruitment period were invited to participate in the study. Consenting individuals were randomly assigned to either the PN intervention or usual care group in a 4:1 ratio. The intervention involved BSS non-attenders receiving a phone call from an SSP to elicit their reasons for non-attendance and offer educational, practical and emotional support as required. If requested by the patient, another BSS appointment was then scheduled. The number of non-attenders in the intervention group who were navigated and then rebooked and attended their new BSS appointment. Barriers to BSS attendance, patient-reported outcomes including informed choice and satisfaction with BSS and the PN intervention, reasons for study non-participation, SSPs' evaluation of the PN process and a cost analysis. Of those invited to take part (n=1050), 152 (14.5%) were randomised into the study: PN intervention=109; usual care=43. Most participants attended their BSS appointment (PN: 79.8%; control: 79.1%) leaving 22 eligible for PN: only two were successfully contacted. SSPs were confident in delivering PN, but were concerned that low BSS awareness and information overload may have deterred patients from taking part in the study. Difficulty contacting patients was reported as a burden to their workload. PN, as implemented, was not a feasible intervention to increase BSS uptake in South Tyneside. Interventions to increase BSS awareness may be better suited to this population. ISRCTN13314752; Results.
Identifiants
pubmed: 30772850
pii: bmjopen-2018-023801
doi: 10.1136/bmjopen-2018-023801
pmc: PMC6398706
doi:
Banques de données
ISRCTN
['ISRCTN13314752']
Types de publication
Clinical Trial, Phase II
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e023801Subventions
Organisme : Department of Health
ID : PB-PG-0613-31021
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Am J Gastroenterol. 2010 Jan;105(1):188-98
pubmed: 19826409
Cancer. 2017 Sep 1;123(17):3356-3366
pubmed: 28464213
Prev Med. 2001 Jun;32(6):502-13
pubmed: 11394954
Soc Sci Med. 2001 Sep;53(5):679-91
pubmed: 11478546
Pilot Feasibility Stud. 2016 Sep 14;2:54
pubmed: 27965871
Fam Community Health. 2001 Oct;24(3):34-47
pubmed: 11563943
Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):506-11
pubmed: 25378365
Am J Prev Med. 2010 May;38(5):508-16
pubmed: 20409499
J Med Screen. 2016 Jun;23(2):77-82
pubmed: 26387824
BMC Public Health. 2018 Oct 05;18(1):1161
pubmed: 30290783
Am J Prev Med. 2017 Sep;53(3):363-372
pubmed: 28676254
J Urban Health. 2006 Mar;83(2):139-41
pubmed: 16736361
BMJ Qual Improv Rep. 2014 Aug 15;3(1):
pubmed: 27493734
JAMA Intern Med. 2017 Jul 1;177(7):967-974
pubmed: 28505217
Cancer. 2011 Aug;117(15 Suppl):3539-42
pubmed: 21780088